BACKGROUND Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more than 70% in HCV genotype 1 patients, there are several problems to be resolved, including skin ras...

Introdução: Manifestações neurológicas já foram relacionadas a Covid-19 e são divididas em três categorias: sistema nervoso central (tontura, cefaleia, doença cerebrovascular, convulsão alteração de consciência), periférico (anosmia, ageusia, deficiência visual, dor neuropática, síndrome Guillain-Barré variantes) lesão muscular esquelética. A presença, especial, cefaleia varia 2,8% 71,1% [1], a...

BACKGROUND Loss of the sense of taste is common among older people. Morbidities and polypharmacy may contribute to the age-related decline in gustatory function. The aims of the present study were to investigate taste perception in elderly hospitalized patients by comparing their taste recognition thresholds with those of healthy, free-living elderly individuals and to identify potential determ...

Introduction: COVID-19 pandemic is spread by droplet infectionwith symptoms of fever, cough,diarrhea,dyspnea, fatigue, myalgia, headache, anosmia and ageusia. Morbidity mortality higher amongelderly in patients with comorbidities especially Diabetes Mellitus(DM). Biomarkers inflammationare potential predictors for prognosis covid patients.Aim: To analyze the association NLR 19 diabetic status O...

Objetivo: Delimitar as manifestações de aspecto neurológicos provocadas pela infecção pelo Sars-Cov-,2 vírus causador da COVID-19. Revisão Bibliográfica: O SARS-CoV-2 é um predominantemente relacionado a clínicas no sistema respiratório, mas atualmente exibe evidências consistentes que apontam para o acometimento do nervoso, evidenciando neurotropismo. Os sintomas mais frequentemente relatados ...

The disease caused by the new SARS-CoV-2 coronavirus (COVID-19) spread rapidly from China to entire world. Approx-imately one third of SARS-CoV-2-infected patients have neurological disorders, especially those classified as severe cases and that require mechanical ventilation. On other hand, almost nine out 10 admitted an Intensive Care Unit could not breathe spontaneously, thus requiring invas...

Abstract The WHO defines a possible case of COVID-19 as person experiencing fever, cough, shortness breath, and neurological signs including anosmia, ageusia, or dysgeusia. However, experiences from hospitals all over the world have shown that presentations vary widely. Some atypical include cardiac, gastrointestinal, neurological, cutaneous while some are driven by inflammatory response, other...

Aim Coronavirus disease 2019 (COVID-19) is a serious that has spread worldwide. In the absence of any effective treatment for mild-to-moderate-stage COVID-19, we report treating patients with Kampo medicines could reduce or prevent progression. Herein, current status COVID-19 medicine, saikatsugekito. Methods The clinical course in treated saikatsugekito was retrospectively investigated from Ja...

BACKGROUND AND OBJECTIVES The laryngeal mask has been frequently used in Anesthesiology. Although the rate of complications with this technique is smaller than that of the endotracheal tube, it is not devoid of risks, especially in cases of difficult airways. The objective of this study was to report a case of unilateral lingual nerve damage after the use of the laryngeal mask airway. CASE RE...